SST and pituitary gland adenoma: Since SST2 is the SST subtype mostly expressed in the majority of pituitary adenomas and NENs, and first-generation SRLs mainly target SST2, most studies focused on the differential activation of this specific SST subtype when investigating the biological differences between PAS and the other SRLs.